LabCorp Invests $2m in SynapDx Corporation
SynapDx Corporation has secured $2 million in funding from Laboratory Corporation of America® Holdings. This investment will support the clinical development of SynapDx’s blood-based autism spectrum disorder diagnostic test, designed to help clinicians identify children with autism earlier than they do today.
25 February 2013•2 mins read
